Posts

Posted on

PIMCO Canada Corp. Announces Quarterly Distributions for PIMCO Canada Exchange Traded Series

Not for distribution to United States newswire services or for dissemination in the United States

TORONTO, March 17, 2021 (GLOBE NEWSWIRE) — PIMCO Canada Corp. (“PIMCO Canada”) today announced the 2021 first quarter cash distributions for the ETF series (“ETF Series”) of the PIMCO Canada mutual funds that distribute quarterly (“Funds”). Unitholders of record of the ETF Series, at the close of business on March 24, 2021, will receive a per-unit cash distribution payable on or about March 31, 2021.

Details of the per-unit cash distribution amount are as follow:

Fund Name Ticker Cash Distribution per Unit
PIMCO Managed Conservative Bond Pool PCON $0.24429
PIMCO Managed Core Bond Pool PCOR $0.06959

The Manager, PIMCO Canada administers and manages the PIMCO Canada ETFs, and retains Pacific Investment Management Company, LLC (“PIMCO”), to provide sub-advisory services to the Funds.

About PIMCO

PIMCO was founded in 1971 in Newport Beach, California and is one of the world’s premier fixed income investment managers. Today we have offices across the globe and 3,000+ professionals united by a single purpose: creating opportunities for investors in every environment. PIMCO is owned by Allianz S.E., a leading global diversified financial services provider.

Forward-Looking Statements

Certain statements included in this news release constitute forward-looking statements, including, but not limited to, those identified by the expressions “expect”, “intend”, “will” and similar expressions to the extent they relate to the Funds. The forward-looking statements are not historical facts but reflect the Funds’, PIMCO Canada’s and/or PIMCO’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations, including, but not limited to, market factors. Although the Funds, PIMCO Canada and/or PIMCO believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein. The Funds, PIMCO Canada and/or PIMCO undertakes no obligation to update publicly or otherwise revise any forward-looking statement or information whether as a result of new information, future events or other factors which affect this information, except as required by law.

No offering is being made by this material. Interested investors should obtain a copy of the prospectus, which is available from your Financial Advisor.

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.

All investments contain risk and can lose value. For a summary of the risks of an investment in a specific fund, please see the risks of mutual funds section of the prospectus.

Investments made by a Fund and the results achieved by a Fund are not expected to be the same as those made by any other PIMCO-advised Fund, including those with a similar name, investment objective or policies. A new or smaller Fund’s performance may not represent how the Fund is expected to or may perform in the long-term. New Funds have limited operating histories for investors to evaluate and new and smaller Funds may not attract sufficient assets to achieve investment and trading efficiencies. A Fund may be forced to sell a comparatively large portion of its portfolio to meet significant shareholder redemptions for cash, or hold a comparatively large portion of its portfolio in cash due to significant share purchases for cash, in each case when the Fund otherwise would not seek to do so, which may adversely affect performance.

Funds can offer different series, which are subject to different fees and expenses (which may affect performance), having different minimum investment requirements and are entitled to different services.

The products and services provided by PIMCO Canada may only be available in certain provinces or territories of Canada and only through dealers authorized for that purpose.

PIMCO Canada has retained PIMCO LLC as sub-adviser. PIMCO Canada will remain responsible for any loss that arises out of the failure of its sub-adviser.

PIMCO as a general matter provides services to qualified institutions, financial intermediaries and institutional investors. Individual investors should contact their own financial professional to determine the most appropriate investment options for their financial situation. This material contains the current opinions of the manager and such opinions are subject to change without notice. This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. PIMCO is a trademark of Allianz Asset Management of America L.P. in the United States and throughout the world. ©2021, PIMCO

PIMCO Canada Corp. 199 Bay Street, Suite 2050, Commerce Court Station, P.O. Box 363, Toronto, ON, M5L 1G2, 416-368-3350

Contact:
Agnes Crane
PIMCO – Media Relations
Phone: +212 597.1054



Posted on

Victory Square Technologies Provides 2021- Q1 Corporate Update

  • Victory Square plans to invest up to $5,000,000 to start commercializing ventures working on the following: EV Solutions, Renewable Energy, Plant-Based Comfort Foods, Digital Assets Management, NFT for Music, Telehealth service for PETS, and Fractional Trading
  • Completed Acquisition of IV Hydreight, An On-Demand & On-Site Mobile Health, Pharmaceutical & Wellness Service Provider Across the USA
  • GameOn completed an oversubscribed $5,800,000 pre-listing finance round
  • Victory Square Technologies Announced GameOn Share Dividend Initiative for VST Shareholders
  • FansUnite (CSE:FANS) completed an oversubscribed $13,000,000 financing
  • Immersive Tech announced the Creation of the World’s First COVID-safe Location-Based Entertainment Virtual Reality Division “UNCONTAINED”
  • Completed $6,000,000 Sale of VPN Platform to Cloud Nine Web3 (CSE:CNI)
  • Exercised 350,000 warrants in Argo Blockchain PLC for a $1,488,000 gain (as at March 15th, 2021)

VANCOUVER, British Columbia, March 17, 2021 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides investors access to a diverse portfolio of next generation internet companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to provide a corporate update for Q1 2021.

Victory Square reported record net income for the nine-month period ending September 30, 2020, of $13,617,124 and earnings per share of $0.18. The Company maintained this pace in Q4 2020, closing out the year strong. Victory Square’s 2020 Year End Financials will be released on or before April 30th, 2021, and its 2021 Q1 Financials will be released on or before May 31st, 2021.

The positive momentum from 2020 has continued into Q1 2021, below are some recent highlights:

Victory Square is planning to invest up to $5,000,000 to start commercializing ventures that have been incubating in stealth mode. Ventures are working on the following:

  • EV Solutions, Hardware & Software
  • Renewable Energy (Solar)
  • Plant-Based Comfort Foods (Patties, Crumbles, Meatballs)
  • Digital Assets Management (Focused on Layer 2, DeFi and NFT applications)
  • NFT for Music
  • Telehealth service for PETS
  • Telehealth Services for Mental Health
  • Fractional Trading Platform



FansUnite


(Vertical: Sports Betting, eSports, Gaming)

FansUnite (CSE:FANS)(OTCQB: FUNFF) is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and related products.

Highlights:

  • Completed an oversubscribed $13,000,000 private placement
  • Applied for key UK Gaming License to operate across Britain
  • Received a Gaming License and Gaming Supply License from the country of Malta, which enables the Company to offer B2B and B2C gaming services throughout Europe.



GameOn


(Vertical: Mobile Gaming, eSports)
GameOn is a gaming company providing consumers, broadcasters, sports books, venues and brand partners with interactive, social experiences around sports, television and live events. GameOn drove engagement and revenue through its suite of proprietary mobile and TV technologies, changing the way fans compete, watch and win through free and frictionless prediction games.

Highlights:

  • Completed oversubscribed $5,800,000 private placement
  • Announced significant additions to the Board, Advisory and Management teams: J. Moses (Take Two Interactive), Mike Vorhaus (Draft Kings, Roblox), Sean Hurley (Draft Kings), and Santiago Jaramillo (FIFA at EA Sports, NBA Top Shot at Dapper Labs)
  • Public listing scheduled for March/April 2021



Immersive Tech


(Vertical: VR/AR/MR)

Immersive Tech designs, programs, builds and installs immersive and engaging experiences for some of the world’s leading companies. Through a blend of video game development, theme park engineering and the latest VR/AR/MR technologies, the company has amassed a portfolio working with many global brands including: Intel, Snickers, Bayer, Ardbeg, USFDA, Scotia Bank and Capital One among others.

Highlights:

  • Company announced launch of “UNCONTAINED” the next evolution in hyper-immersive VR attractions for launch in Summer 2021
  • Immersive Tech’s UNCONTAINED project / attraction was Featured in Forbes
  • Announced the hire of Steven Dooner. Dooner’s remarkable record of career accomplishments showcase his most notable franchise endeavors, involving the expansion of distinguished entities including Chuck E Cheese, ESPNZone, and a series of Disney launches with Club Disney, DisneyQuest, and the expansion of Tokyo Disneyland.
  • Public listing scheduled for Q2of 2021.



Covalent


(Vertical: Fintech, Crypto)

The data powering the De-Fi economy. Covalent provides a unified API to bring full transparency and visibility to assets across all blockchain networks.

Highlights:

Cloud Nine Web3 Technologies (Vertical: Web 3.0, EdTech)

Cloud Nine Web3 Technologies is an EdTech company, with a mission to fuel innovation in the education sector. Cloud Nine’s opportunities and partnerships are strategically positioned to capitalize on the dominance of emerging technologies and the growing need to learn faster and easier from experts in collaboration with key educators and influencers in the marketplace.

Highlights:

  • Completed acquisition of VPN Platform
  • Launched new Education Technology Platform designed to provide users with easy and simple guides to cybersecurity, wearable technologies, blockchain technology, cryptocurrencies, and decentralized finance
  • Added Web3 Tech Entrepreneur, Pavel Bains, CEO of Bluzelle, as Strategic Advisor



Hydreight


(Vertical: Digital Health, Pharmacy, Diagnostics)

Founded in 2018, Hydreight provides a unique, custom built, proprietary telemedicine service that allows users to book confidential health & wellness and/or medical services at their home, hotel, office or wherever they may need discreet assistance. The business model of Hydreight leverages decentralized healthcare to bring quality telehealth, medical, health and wellness services to the masses in an efficient, scalable and cost effective way.

Highlights:

  • The Company is on track to project for $5,000,000 in revenues in 2021
  • Hydreight’s proprietary technology is HIPPA compliant
  • The Company has a 503B pharmacy license , and is a U.S. Certified e -script and telemedicine provider, allowing Hydreight to service all 50 states
  • In addition to providing telehealth services, other products include IV Drip, Botox, COVID – 19 testing and other medical and medispa treatments.
  • Expanding its offering to South America and Canada

VS Health (Vertical: Digital Health, Tele-Pet & Diagnostics)

VS Health is 360-degree health care offering smart, connected devices, at-home diagnostic tests, personalized digital guidance and monitoring, 24/7/365 access to health care professionals, and prescription delivery.

Highlights:

  • Teaming up with Hydreight to launch one-stop-shop virtual health care platform (telemedicine, virtual pharmacy, at-home point-of-care diagnostic testing) in Brazil
  • Launch of Telehealth service for PETS – The first fully integrated on demand health and wellness service for domesticated animals and their owners
  • In just a six month period; VSH has seen a substantial valuation increase from $5M value in February 2020, to a $65M valuation in September of 2020.
  • VSH has signed distribution agreements with Health Canada approved Covid-19 testing suppliers while it awaits approval for its products from Health Canada

Copilot AI (Vertical: Sales and Marketing Automation)

CoPilot AI is a Software-as-a-Service (SaaS) company based in Vancouver, Canada. The company’s mission is to fundamentally change the way people connect with businesses. CoPilot AI is a BC Technology Impact Award finalist, and is named by Canadian Business as the winner of the Best Pivot award and one of Canada’s Fastest-Growing Companies.

Highlights:

  • The company is accelerating revenue growth, moving from a well-heeled start-up to a high-growth SaaS venture, scaling business activities and expansion.
  • Further fuelling this acceleration is the ongoing hiring of senior personnel who have already participated in successfully driving existing technology companies into global dominance.
  • Copilot AI’s momentum has seen quarterly double-digit growth drive their product offerings into new sectors and industries with excellent early adoption and customer feedback.

Philanthropic Contributions:

VST is dedicated to giving back to the communities in which it serves and operates. The Company’s mandate is to assist organizations through its time, talent and treasure. The Company is committed to organizations that provide services in the youth, mental health, special needs, sport, tech, education, marginalized groups, First Nations, and accessibility sectors.

The company recently contributed $500,000 in donations to: Variety The Children Charity of BC, CKNW KIDS FUND, Simon Fraser University Tech Camp, The BC Sports Hall of Fame & Museum, Covenant House Vancouver, YWCA, Coast Mental Health, The Cerebral Palsy Association of BC, and the BC Children’s Hospital Foundation. These gifts are in conjunction with VST’s “GIVING BACK” pledge made by its Executive, Staff, and Board.

Visit VictorySquare.com and sign up for the official newsletter of Victory Square at www.VictorySquare.com/newsletter.

On behalf of the board,

Shafin Diamond Tejani
Chief Executive Officer

For further information about the Company, please contact:

Investor Relations Contact – Edge Communications Group
Email: [email protected] 
Telephone: 604 283-9166

Media Relations Contact – Howard Blank, Director
Email: [email protected] 
Telephone: 604-928-6066

ABOUT VICTORY SQUARE TECHNOLOGIES INC.

Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.
VST’s sweet spot is the cutting-edge tech that’s shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.

What we do differently for startups

VST isn’t just another investor. With real skin in the game, we’re committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you’ll scale and be ready to monetize.

What we do differently for investors

VST is a publicly-traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).

For investors, we offer early-stage access to the next unicorns before they’re unicorns. Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies. Because we focus on market-ready solutions that scale quickly, we’re able to provide strong and stable returns while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.

ABOUT THE CANADIAN SECURITIES EXCHANGE (CSE)

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

FORWARD-LOOKING INFORMATION

This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.



Posted on

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

PR Newswire

LOS ANGELES, March 17, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Immunovant, Inc. (“Immunovant” or “the Company”) (NASDAQ: IMVT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between October 2, 2019 and February 1, 2021, inclusive (the ”Class Period”), are encouraged to contact the firm before April 20, 2021. 

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Health Sciences Acquisitions Corporation failed to perform proper due diligence into Immunovant Sciences Ltd. prior to the merger, and ignored or failed to disclose safety problems with IMVT-1401. IMVT-1401 was not as safe as the Company led the market to believe, particularly for the treatment of thyroid eye disease (TED) and warm autoimmune hemolytic anemia (WAIHA). These issues would greatly impact the likelihood of IMVT-1401 securing regulatory approval and commercial viability. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Immunovant, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investor-action-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-immunovant-inc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301249404.html

SOURCE The Schall Law Firm

Posted on

Scripps taps Kate O’Brian to lead enterprise journalism for national networks division

PR Newswire

CINCINNATI, March 17, 2021 /PRNewswire/ — The E.W. Scripps Company (NASDAQ: SSP) has appointed award-winning network news executive Kate O’Brian as head of news for its national television networks business, effective April 12.

In this newly created role, O’Brian will be responsible for the news and programming strategy for Scripps Networks’ news brands Newsy and Court TV, upholding the company’s commitment to quality, objective journalism. She will report to Scripps Networks President Lisa Knutson.

“Kate’s career has taken her around the world to report on events that have shaped our culture and shared experiences,” Knutson said. “She brings a depth of editorial experience, journalistic integrity and curiosity that aligns with our ethos and our commitment to straightforward, opinion-free news and enterprise journalism.

“In addition, her executive management experience – including leading national news operations, driving transformational change and launching successful news products – will help Scripps Networks write the next chapter of growth and audience engagement for Newsy and Court TV.”

O’Brian’s esteemed career in news and journalism spans nearly four decades. She spent 30 years at ABC News in ascending positions. As senior vice president for news, O’Brian oversaw newsgathering across ABC’s news bureaus worldwide; business, law and justice, medical and investigative units; as well as NewsOne, ABC News Radio and affiliate relations. Also while at ABC News, O’Brian served as general manager of programming for ABC News Radio; as overseas field producer in Rome and London; as producer for “World News Tonight with Peter Jennings“; and as manager of talent development.

O’Brian became the first woman to run a 24/7 cable news organization when she was appointed president at Al Jazeera America, leading the startup news network to multiple awards. Most recently, she has consulted with media organizations on a range of editorial, management and business strategies, working with some of the country’s leading news operations.

Among other awards, O’Brian’s work has been honored with an Alfred I. duPont-Columbia University Award, an Emmy Award and a George Foster Peabody Award.

O’Brian earned a bachelor’s degree from Smith College in Massachusetts.

Newsy is the television news network that provides straightforward, opinion-free news to inform and engage by delivering the top stories across multiple platforms. Court TV is the only multi-platform network devoted to live, gavel-to-gavel coverage, in-depth legal reporting and expert analysis of the nation’s most important and compelling trials. Scripps Networks also includes the popular entertainment brands ION, Bounce, Grit, Laff and Court TV Mystery.


About Scripps


The E.W. Scripps Company (NASDAQ: SSP) is a diversified media company focused on creating a better-informed world. As the nation’s fourth-largest local TV broadcaster, Scripps serves communities with quality, objective local journalism and operates a portfolio of 61 stations in 41 markets. The Scripps Networks reach nearly every American through the national news outlets Court TV and Newsy and popular entertainment brands ION, Bounce, Grit, Laff and Court TV Mystery. Scripps is the nation’s largest holder of broadcast spectrum. Scripps runs an award-winning investigative reporting newsroom in Washington, D.C., and is the longtime steward of the Scripps National Spelling Bee. Founded in 1878, Scripps has held for decades to the motto, “Give light and the people will find their own way.”

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/scripps-taps-kate-obrian-to-lead-enterprise-journalism-for-national-networks-division-301249452.html

SOURCE The E.W. Scripps Company

Posted on

Morningstar Reports U.S. Mutual Fund and Exchange-Traded Fund Flows for February 2021

PR Newswire

CHICAGO, March 17, 2021 /PRNewswire/ — Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, today reported estimated U.S. mutual fund and exchange-traded fund (ETF) flows for February 2021. For the month of February, long-term mutual funds and ETFs collected a record $144 billion. ETFs collected approximately $92 billion, driven by a move into equity funds, while open-end funds took in $53 billion, led by flows into fixed-income strategies.

Morningstar’s report about U.S. fund flows for February 2021 is available here. Additional highlights from the report include:

  • Interest rate- and commodity-sensitive categories, such as financial and natural resource equity funds and inflation-protected bond funds, saw sharp organic growth. For example, natural resource funds, which tend to focus on materials stocks, took in nearly $2.5 billion, the highest monthly inflow in the past decade. Inflation-protected bond funds collected nearly $7 billion in February, a record for the category.
  • Among U.S. category groups, U.S. equities took in a record $38 billion in February, almost recouping January’s outflows. Large-blend funds took in the most assets of any category at $22 billion.
  • Sector equity funds attracted a record monthly inflow of $25 billion. Technology-themed funds led the way, gathering over $7 billion. Technology funds’ month-over-month organic growth rate of 2.5% was the highest since November 2015.
  • Taxable bonds had another strong month in February, taking in approximately $57 billion for the month, bringing their total over the trailing 12 months to $493 billion, the most by far of any category group.
  • Among fund families, Vanguard had approximately $37 billion of inflows, of which $34 billion went to passive strategies, while iShares followed with inflows of $16 billion. American Funds, an active manager, took in nearly $3 billion, with $1.6 billion entering American Funds Bond Fund of America.

To view the complete report, please click here.

The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed outside the scope of this press release; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

About Morningstar, Inc.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The Company offers an extensive line of products and services for individual investors, financial advisors, asset managers, retirement plan providers and sponsors, and institutional investors in the debt and private capital markets. Morningstar provides data and research insights on a wide range of investment offerings, including managed investment products, publicly listed companies, private capital markets, debt securities, and real-time global market data. Morningstar also offers investment management services through its investment advisory subsidiaries, with approximately $227 billion in assets under advisement and management as of Dec. 31, 2020. The Company has operations in 29 countries. For more information, visit www.morningstar.com/company. Follow Morningstar on Twitter @MorningstarInc.

Morningstar’s Manager Research Group consists of various wholly owned subsidiaries of Morningstar, Inc. including, but not limited to, Morningstar Research Services LLC. This press release is for informational purposes only; references to securities or a separately managed account investment strategy in this press release should not be considered an offer or solicitation to buy or sell the securities or to invest in accordance with that strategy.

©2021 Morningstar, Inc. All Rights Reserved.

MORN-R

Media Contact:
Sarah Wirth, +1 312 244-7358 or [email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/morningstar-reports-us-mutual-fund-and-exchange-traded-fund-flows-for-february-2021-301249532.html

SOURCE Morningstar, Inc.

Posted on

Unibail-Rodamco-Westfield completes the disposal of the Village 3, 4 and 6 office buildings


 

Paris, Amsterdam, March 17, 2021

           Press release

Unibail-Rodamco-Westfield completes the disposal of the Village 3, 4 and 6 office buildings

Unibail-Rodamco-Westfield (URW) today announces the completion of the disposals of the Village 3, 4 and 6 office buildings, located in La Défense (Paris region) to French institutional investors. Agreements for the disposals were signed in December 2020.

Village 3 was sold to an institutional fund managed by La Française Real Estate Managers on March 4, 2021.
Village 4 and 6 were sold to institutional funds managed by Perial AM on March 17, 2021.
The total Net Disposal Price1 of both transactions is €213 Mn. With these transactions, and the completion of the SHiFT disposal earlier this year, €0.8 Bn of the €4 Bn European asset disposal programme has been completed.

URW was advised by Ginisty & Associés and Lacourte Raquin Tatar. La Francaise Real Estate Managers was advised by Allez & Associés and Fairway and Perial AM was advised by Oudot & Associés and Ashurst.

For further information, please contact:

Investor Relations
Samuel Warwood 
Maarten Otte 
+33 1 76 77 58 02 
[email protected]

Media Relations 

Céline van Steenbrugghe
+33 6 71 89 73 08
[email protected]

About Unibail-Rodamco-Westfield

Unibail-Rodamco-Westfield is the premier global developer and operator of Flagship Destinations, with a portfolio valued at €56.3 Bn as at December 31, 2020, of which 85% in retail, 8% in offices, 5% in convention & exhibition venues and 2% in services. Currently, the Group owns and operates 87 shopping centres, including 53 Flagships in the most dynamic cities in Europe and the United States. Present on two continents and in 12 countries, Unibail-Rodamco-Westfield provides a unique platform for retailers and brand events and offers an exceptional and constantly renewed experience for customers.
With the support of its 3,100 professionals and an unparalleled track-record and know-how, Unibail-Rodamco-Westfield is ideally positioned to generate superior value and develop world-class projects.
Unibail-Rodamco-Westfield distinguishes itself by its Better Places 2030 agenda, that sets its ambition to create better places that respect the highest environmental standards and contribute to better cities.
Unibail-Rodamco-Westfield stapled shares are listed on Euronext Amsterdam and Euronext Paris (Euronext ticker: URW), with a secondary listing in Australia through Chess Depositary Interests. The Group benefits from an BBB+ rating from Standard & Poor’s and from a Baa2 rating from Moody’s.

For more information, please visit www.urw.com
Visit our Media Library at https://mediacentre.urw.com
Follow the Group updates on Twitter @urw_group, Linkedin @Unibail-Rodamco-Westfield and Instagram @urw_group

1 Net Disposal Price: Total Acquisition Cost incurred by the acquirer minus all transfer taxes and transaction costs

 

Attachment



Posted on

SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action Suit Against BELLUS Health Inc.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action Suit Against BELLUS Health Inc.

LOS ANGELES–(BUSINESS WIRE)–
The Schall Law Firm and Roche Freedman LLP announced today that they have filed a securities class action lawsuit on behalf of plaintiff Carl D. Cachia against BELLUS Health Inc. (“BELLUS” or “the Company”) (NASDAQ: BLU) and certain of its officers. The class action, filed in the Southern District of New York, captioned Cachia v. BELLUS Health Inc., et. al., and docketed under Case No. 1:21-cv-02278, is on behalf of a class consisting of investors who purchased or otherwise acquired BELLUS securities between September 5, 2019 and July 5, 2020, inclusive (the ”Class Period”). Plaintiff seeks to recover compensable damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder.

If you are a shareholder who purchased BELLUS securities during the Class Period, you have until May 17, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

BELLUS is a clinical-stage biopharmaceutical company whose lead product is BLU-5937, which is being developed for the treatment of chronic cough (one that lasts over eight weeks) and other afferent hypersensitization-related disorders. The Complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts about BELLUS’s business, operations, drug products, drug product development, competition, and present and future business prospects. Specifically, Defendants misrepresented and/or failed to disclose that BLU-5937’s “high selectivity” contributed to the drug potentially being less efficacious and thus likely unable to meet the primary endpoint of the Company’s Phase 2 study. As a result, when Defendants announced before markets opened on July 6, 2020, that BLU-5937 had failed the Phase 2 study, the Company’s stock price plummeted over 75% on heavy trading volume.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm

Brian Schall, Esq.

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

Applying New 3Rs Gets Workers through Pandemic, Global Author/CEO Says

PR Newswire

SALT LAKE CITY, March 17, 2021 /PRNewswire/ — Applying the new 3Rs, resilience, recalibration and relationships, will help today’s workers get through challenges brought by the pandemic, according to a global author and CEO.

“The first thing to acknowledge is that every person who has made it this far through the pandemic is resilient, and that is a key strength that is going to carry us through to even greater heights,” said Kevin Guest, author of the bestseller, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony. “Years ago, I met the most famous diamond in the world: the Hope Diamond. As I held this forty-five-and-a-half carat, deep blue diamond in my hands, it made me think of how resilient this rock is to have withstood the highly pressured environment in the earth.

“From about 90 miles deep in the earth, this rock was spewed out in a volcanic eruption, discovered, cleaned, polished and prepared into a beautiful diamond. In a metaphorical sense, each one of us is a diamond, and through all of the pressures of the pandemic, we have strengthened our character and determination to make us unstoppable.”

The second “R” to recalibrate your life to align with your core values is a repeated theme in Guest’s book, which has been printed and sold in five languages, i.e., English, Traditional Chinese, Simplified Chinese, Spanish and Korean.

“We have never been closer to the end of the pandemic than we are now,” said Guest. “Living in isolation is the perfect time to reconnect with your core values to determine who you really are, what life means to you and what values will serve as your foundation going forward.

“In reality, most of us have never been given the gift of extended time to assess like we have now. Using this to determine what matters most to you is a huge life bonus. Recalibrating habits, thoughts and daily duties to define who you are will benefit you and those around you for the rest of your life.”

Drawn from a lifetime of networking and leading a global company, Guest cites the third “R” as valuing relationships.

“Nothing is more important than relationships,” said Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), a billion-dollar company operating in 24 markets worldwide. “Today I have friends and colleagues in countries and cultures around the world, and each are important to me. I learned long ago that treating others with the utmost respect and kindness is a key to success and makes life more harmonious for everyone.

“The pandemic has reminded us of things that matter most, and relationships with others is at the top of the list as we connect with God, family, friends, coworkers and so forth. Over the last year, we have felt a loss of connection with others, and because humans are naturally social beings, relationship-building is one of the key factors that will help us emerge strong from the pandemic.”

Guest believes those simple patterns of behavior can help us power through the pandemic and lift each other to higher levels of harmony in life in a post-pandemic world.

“I’ve never seen Kevin make a selfish decision,” said country music star Collin Raye, who wrote the forward in All the Right Reasons and frequently invites Guest to play with his band on tour, including multiple times at the Grand Ole Opry. “He thinks of his family, his friends, and his associates at USANA and always tries to put others first.”

All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony is available on Amazon. All proceeds feed hungry children, with each book purchase providing 40 meals.

For more information, visit www.kevinguest.com.

MEDIA CONTACT: 
Tim Brown, Candid Communications 
[email protected] 
801-557-1466 m 

Cision View original content:http://www.prnewswire.com/news-releases/applying-new-3rs-gets-workers-through-pandemic-global-authorceo-says-301249535.html

SOURCE USANA

Posted on

IIROC Trading Resumption – BHT

Canada NewsWire

VANCOUVER, BC, March 17, 2021 /CNW/ – Trading resumes in:

Company: Braveheart Resources Inc.

TSX-Venture Symbol: BHT

All Issues: Yes

Resumption (ET): 1:15 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Posted on

Provation and Iterative Scopes Announce Exclusive AI Partnership

Collaboration seeks to advance artificial intelligence (AI) in gastroenterology (GI) and data-driven healthcare for better patient outcomes.

Minneapolis, MN and Cambridge, MA, March 17, 2021 (GLOBE NEWSWIRE) — Provation and Iterative Scopes announced today an exclusive partnership, bringing together the premier clinical productivity and gastroenterology (GI) documentation software provider with a leading startup in Artificial Intelligence (AI) for precision GI.

Through this partnership, the two companies are focused on delivering AI-based solutions to healthcare providers and life science researchers, including AI-assisted diagnostic tools, procedure documentation, and clinical trial recruitment.

One of the first initiatives under the partnership will be an AI-based patient recruiting solution for inflammatory bowel disease (IBD) patients. This new recruitment method is expected to accelerate the time needed to bring new therapies to market, bypassing many of the problems pharmaceutical companies currently face.

“Our partnership with Iterative Scopes is a logical one. Provation is the market leader in GI documentation, with more than 3,500 customer facilities including 80% of the top academic and large health systems. Our IBD data can enable Iterative Scopes to facilitate clinical trial recruitment and deliver clinical endpoint evaluations to their pharmaceutical partners,” said Craig Moriarty, Provation Senior Vice President of Strategy and Product. “In addition, Iterative Scopes can bring its extensive AI toolkit to our GI documentation solutions, including Provation® Apex.”

The integration of these technology platforms will enable more efficient and accurate documentation of gastroenterology procedures benefiting physicians and the patients they serve.

“I am thrilled to partner with Provation, to accelerate the adoption of AI into gastroenterology and to be able to learn from the deep expertise and trusted position Provation holds. We look forward to unlocking tremendous value for patients, physicians and life science partners.” said Jonathan Ng, CEO, Iterative Scopes.

 

About Iterative Scopes

Iterative Scopes is a gastrointestinal data company, working to deliver AI toolkits to the practice of gastroenterology by providing real-time, actionable insights to providers and the life sciences. Spun out of MIT in 2017, the team has since raised $14M in funding and is based out of Cambridge, Massachusetts. For more information, visit iterativescopes.com.

About Provation 

Provation is a leading provider of healthcare software and SaaS solutions. Our purpose is to empower providers to deliver quality healthcare for all. We provide innovative solutions in clinical productivity, care coordination, quality reporting and billing. Celebrating 25 years, Provation serves thousands of hospitals, surgical facilities, anesthesia groups, and medical offices, including 43 of the top 50 U.S. hospitals for gastroenterology (GI) and GI surgery. Our comprehensive portfolio spans the entire patient procedure, from pre-op through post-op recovery and follow-up, with solutions for physician and nursing documentation (Provation® MD, Provation® Apex, MD-Reports and Provation® MultiCaregiver), patient engagement, surgical care coordination, quality reporting, and billing capture (Provation® SurgicalValet™), order set and care plan management (Provation® Order Set Advisor and Provation® Care Plans), and EHR embedded clinical documentation (Provation® Clinic Note). Provation is headquartered in Minneapolis, MN and backed by Clearlake Capital Group, L.P. For more information about our solutions, visit provationmedical.com.

Attachments 



Tristan Galvan
Provation
612.313.1548
[email protected]

Sahir Raoof
Iterative Scopes
[email protected]